# Vysioneer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vysioneer

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, US
- Website: www.vysioneer.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Jun 1, 2023)
- Investors on record: 1

## About

Based in Massachusetts, US, and founded in 2019 by Chief Executive Officer Jen-Tang, Vysioneer Inc. operates as a medical devices manufacturing company providing an oncology artificial intelligence platform that provides a food and drug administration-cleared technology for enhancing tumor heterogeneity clarity in cancer treatment. In February 2024, Vysioneer Inc. raised USD 1.7 million in seed funding led by Chaac Ventures.

Vysioneer Inc. developed VBrain, which is an FDA-cleared AI-powered brain tumor auto-contouring solution and applies auto-contouring to three common types of brain tumors such as brain metastasis, meningioma, and acoustic neuroma. The company’s device enhances precision and productivity in tumor measurement, leading to increased accuracy and pinpoint contouring. In addition, the firm leverages oncology AI to enhance cancer treatment by providing lesion-level insights into drug efficacy.

## Funding rounds

- Seed, Jun 1, 2023, $0.8M — Chaac Ventures

## Investors

- Chaac Ventures (https://capitalatlas.ai/funds/chaac-ventures) — Seed